RATIONALE: Chronic marijuana (MJ) use among adolescents has been associated with structural and functional abnormalities, particularly in developing regions responsible for higher order cognition. OBJECTIVES: This study investigated prefrontal (PFC) and parietal volumes and executive function in emerging adult MJ users and explored potential gender differences. METHODS: Participants (ages 18-25) were 27 MJ users and 32 controls without neurologic or psychiatric disorders or heavy other drug use. A series of multiple regressions examined whether group status, past year MJ use, and their interactions with gender predicted ROI volumes. Post hoc analyses consisted of brain-behavior correlations between volumes and cognitive variables and Fisher's z tests to assess group differences. RESULTS: MJ users demonstrated significantly smaller medial orbitofrontal (mOFC; p = 0.004, FDR p = 0.024) and inferior parietal volumes (p = 0.04, FDR p = 0.12); follow-up regressions found that increased past year MJ use did not significantly dose-dependently predict smaller mOFC volume in a sub-sample of individuals with at least one past year MJ use. There were no significant gender interactions. There was a significant brain-behavior difference by group, such that smaller mOFC volumes were associated with poorer complex attention for MJ users (p < 0.05). CONCLUSIONS: Smaller mOFC volumes among MJ users suggest disruption of typical neurodevelopmental processes associated with regular MJ use for both genders. These results highlight the need for longitudinal, multi-modal imaging studies providing clearer information on timing of neurodevelopmental processes and neurocognitive impacts of youth MJ initiation.
RATIONALE: Chronic marijuana (MJ) use among adolescents has been associated with structural and functional abnormalities, particularly in developing regions responsible for higher order cognition. OBJECTIVES: This study investigated prefrontal (PFC) and parietal volumes and executive function in emerging adult MJ users and explored potential gender differences. METHODS:Participants (ages 18-25) were 27 MJ users and 32 controls without neurologic or psychiatric disorders or heavy other drug use. A series of multiple regressions examined whether group status, past year MJ use, and their interactions with gender predicted ROI volumes. Post hoc analyses consisted of brain-behavior correlations between volumes and cognitive variables and Fisher's z tests to assess group differences. RESULTS:MJ users demonstrated significantly smaller medial orbitofrontal (mOFC; p = 0.004, FDR p = 0.024) and inferior parietal volumes (p = 0.04, FDR p = 0.12); follow-up regressions found that increased past year MJ use did not significantly dose-dependently predict smaller mOFC volume in a sub-sample of individuals with at least one past year MJ use. There were no significant gender interactions. There was a significant brain-behavior difference by group, such that smaller mOFC volumes were associated with poorer complex attention for MJ users (p < 0.05). CONCLUSIONS: Smaller mOFC volumes among MJ users suggest disruption of typical neurodevelopmental processes associated with regular MJ use for both genders. These results highlight the need for longitudinal, multi-modal imaging studies providing clearer information on timing of neurodevelopmental processes and neurocognitive impacts of youth MJ initiation.
Authors: J N Giedd; J Blumenthal; N O Jeffries; F X Castellanos; H Liu; A Zijdenbos; T Paus; A C Evans; J L Rapoport Journal: Nat Neurosci Date: 1999-10 Impact factor: 24.884
Authors: Jennifer J Manly; Diane M Jacobs; Pegah Touradji; Scott A Small; Yaakov Stern Journal: J Int Neuropsychol Soc Date: 2002-03 Impact factor: 2.892
Authors: Golfo K Tzilos; Christina B Cintron; Jonas B R Wood; Norah S Simpson; Ashley D Young; Harrison G Pope; Deborah A Yurgelun-Todd Journal: Am J Addict Date: 2005 Jan-Feb
Authors: Krista Lisdahl Medina; Tim McQueeny; Bonnie J Nagel; Karen L Hanson; Tony T Yang; Susan F Tapert Journal: Addict Biol Date: 2009-07-24 Impact factor: 4.280
Authors: C Paula Lewis-de Los Angeles; Paige L Williams; Yanling Huo; Shirlene D Wang; Kristina A Uban; Megan M Herting; Kathleen Malee; Ram Yogev; John G Csernansky; Sharon Nichols; Russell B Van Dyke; Elizabeth R Sowell; Lei Wang Journal: Brain Behav Immun Date: 2017-01-10 Impact factor: 7.217
Authors: J Cobb Scott; Adon F G Rosen; Tyler M Moore; David R Roalf; Theodore D Satterthwaite; Monica E Calkins; Kosha Ruparel; Raquel E Gur; Ruben C Gur Journal: Neuropsychopharmacology Date: 2019-02-19 Impact factor: 7.853
Authors: Kristin E Maple; Alicia M Thomas; Megan M Kangiser; Krista M Lisdahl Journal: Psychiatry Res Neuroimaging Date: 2019-04-30 Impact factor: 2.376
Authors: Krista M Lisdahl; Leanne Tamm; Jeffery N Epstein; Terry Jernigan; Brooke S G Molina; Stephen P Hinshaw; James M Swanson; Erik Newman; Clare Kelly; James M Bjork Journal: Drug Alcohol Depend Date: 2016-02-06 Impact factor: 4.492
Authors: Jodi M Gilman; Randi M Schuster; Max T Curran; Vanessa Calderon; Andre van der Kouwe; A Eden Evins Journal: Cogn Affect Behav Neurosci Date: 2016-08 Impact factor: 3.282